Paul Bisaro - Net Worth and Insider Trading
Paul Bisaro Net Worth
The estimated net worth of Paul Bisaro is at least $69 Million dollars as of 2024-11-13. Paul Bisaro is the Director of Allergan PLC and owns about 355,900 shares of Allergan PLC (AGN) stock worth over $69 Million. Paul Bisaro is the Executive Chairman of Amneal Pharmaceuticals Inc and owns about 17,000 shares of Amneal Pharmaceuticals Inc (AMRX) stock worth over $157,250. Paul Bisaro is also the Director of Mallinckrodt PLC and owns about 74,820 shares of Mallinckrodt PLC (MCKPF) stock worth over $8,978. Besides these, Paul Bisaro also holds TherapeuticsMD Inc (TXMD) . Details can be seen in Paul Bisaro's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Bisaro has not made any transactions after 2023-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Bisaro
Paul Bisaro Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Bisaro owns 7 companies in total, including TherapeuticsMD Inc (TXMD) , Zoetis Inc (ZTS) , and Amneal Pharmaceuticals Inc (AMRX) among others .
Click here to see the complete history of Paul Bisaro’s form 4 insider trades.
Insider Ownership Summary of Paul Bisaro
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TXMD | TherapeuticsMD Inc | 2022-08-18 | director |
| ZTS | Zoetis Inc | 2015-05-01 | director |
| AMRX | Amneal Pharmaceuticals Inc | 2019-03-12 | director |
 | | 2013-12-12 | director |
| | 2022-06-16 | director |
| | 2023-03-14 | director |
| | 2022-10-31 | director |
Paul Bisaro Latest Holdings Summary
Paul Bisaro currently owns a total of 4 stocks. Among these stocks, Paul Bisaro owns 355,900 shares of Allergan PLC (AGN) as of March 2, 2017, with a value of $69 Million and a weighting of 99.75%. Paul Bisaro owns 17,000 shares of Amneal Pharmaceuticals Inc (AMRX) as of March 12, 2019, with a value of $157,250 and a weighting of 0.23%. Paul Bisaro also owns 74,820 shares of Mallinckrodt PLC (MCKPF) as of March 14, 2023, with a value of $8,978 and a weighting of 0.01%. The other 1 stocks TherapeuticsMD Inc (TXMD) have a combined weighting of 0.01% among all his current holdings.
Latest Holdings of Paul Bisaro
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGN | Allergan PLC | 2017-03-02 | 355,900 | 193.02 | 68,695,818 |
| AMRX | Amneal Pharmaceuticals Inc | 2019-03-12 | 17,000 | 9.25 | 157,250 |
| MCKPF | Mallinckrodt PLC | 2023-03-14 | 74,820 | 0.12 | 8,978 |
| TXMD | TherapeuticsMD Inc | 2021-08-16 | 3,937 | 1.50 | 5,906 |
Holding Weightings of Paul Bisaro
Paul Bisaro Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Bisaro has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 70,000 shares on March 2, 2017, which brought Paul Bisaro around $17 Million.
According to the SEC Form 4 filings, Paul Bisaro has made a total of 0 transactions in Amneal Pharmaceuticals Inc (AMRX) over the past 5 years. The most-recent trade in Amneal Pharmaceuticals Inc is the acquisition of 17,000 shares on March 12, 2019, which cost Paul Bisaro around $203,490.
According to the SEC Form 4 filings, Paul Bisaro has made a total of 1 transactions in Mallinckrodt PLC (MCKPF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mallinckrodt PLC is the acquisition of 5,000 shares on March 14, 2023, which cost Paul Bisaro around $42,350.
More details on Paul Bisaro's insider transactions can be found in the Insider Trading History of Paul Bisaro table.Insider Trading History of Paul Bisaro
- 1
Paul Bisaro Trading Performance
GuruFocus tracks the stock performance after each of Paul Bisaro's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Bisaro is -23.49%. GuruFocus also compares Paul Bisaro's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Bisaro within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Bisaro's insider trading performs compared to the benchmark.
Performance of Paul Bisaro
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.78 | | | | | |
| Relative Return to S&P 500(%) | -5.25 | | | | | |
Paul Bisaro Ownership Network
Ownership Network List of Paul Bisaro
Ownership Network Relation of Paul Bisaro
Paul Bisaro Owned Company Details
What does TherapeuticsMD Inc do?
Who are the key executives at TherapeuticsMD Inc?
Paul Bisaro is the director of TherapeuticsMD Inc. Other key executives at TherapeuticsMD Inc include General Counsel Marlan D Walker , Principal Financial Officer Joseph Ziegler , and CAO and VP of Finance Michael C Donegan .
TherapeuticsMD Inc (TXMD) Insider Trades Summary
Over the past 18 months, Paul Bisaro made no insider transaction in TherapeuticsMD Inc (TXMD). Other recent insider transactions involving TherapeuticsMD Inc (TXMD) include a net purchase of 5,294 shares made by Collins Cooper C. , and a net sale of 19,050 shares made by Marlan D Walker .
In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc (TXMD) in total and bought 5,294 shares, with a net purchase of 5,294 shares. During the past 18 months, 19,050 shares of TherapeuticsMD Inc (TXMD) were sold and 5,294 shares were bought by its insiders, resulting in a net sale of 13,756 shares.
TherapeuticsMD Inc (TXMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
TherapeuticsMD Inc Insider Transactions
Paul Bisaro Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Bisaro. Currently GuruFocus does not have mailing address information for Paul Bisaro.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
